NCT00523991 - Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD). | Biotech Hunter

Enrollment

457

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

July 31, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

tiotropium

Oral inhalation once daily of 18mcg tiotropium via handihaler

DRUG

Placebo

Oral inhalation once daily of placebo matching tiotropium via handihaler

Trial Locations (62)

Unknown

205.365.1003 Boehringer Ingelheim Investigational Site, Birmingham

205.365.1004 Boehringer Ingelheim Investigational Site, Birmingham

205.365.1098 Boehringer Ingelheim Investigational Site, Jasper

205.365.1023 Boehringer Ingelheim Investigational Site, Palo Alto

205.365.1125 Boehringer Ingelheim Investigational Site, San Diego

205.365.1024 Boehringer Ingelheim Investigational Site, Lexington

205.365.1012 Boehringer Ingelheim Investigational Site, Baltimore

205.365.1086 Boehringer Ingelheim Investigational Site, Bloomington

205.365.1006 Boehringer Ingelheim Investigational Site, Rochester

205.365.1085 Boehringer Ingelheim Investigational Site, Omaha

205.365.1010 Boehringer Ingelheim Investigational Site, Albuquerque

205.365.1007 Boehringer Ingelheim Investigational Site, Rochester

205.365.1080 Boehringer Ingelheim Investigational Site, Charlotte

205.365.1118 Boehringer Ingelheim Investigational Site, Cincinnati

205.365.1033 Boehringer Ingelheim Investigational Site, Pittsburgh

205.365.1092 Boehringer Ingelheim Investigational Site, Kingsport

205.365.1122 Boehringer Ingelheim Investigational Site, Clarksburg

205.365.1103 Boehringer Ingelheim Investigational Site, Gilly

205.365.1059 Boehringer Ingelheim Investigational Site, Leuven

205.365.1057 Boehringer Ingelheim Investigational Site, Menen

205.365.1058 Boehringer Ingelheim Investigational Site, Yvoir

205.365.1042 Boehringer Ingelheim Investigational Site, Vancouver

205.365.1056 Boehringer Ingelheim Investigational Site, Kingston

205.365.1104 Boehringer Ingelheim Investigational Site, Toronto

205.365.1041 Boehringer Ingelheim Investigational Site, Ste-Foy

205.365.1064 Boehringer Ingelheim Investigational Site, Cvikov

205.365.1107 Boehringer Ingelheim Investigational Site, Hradec Králové

205.365.1061 Boehringer Ingelheim Investigational Site, Karlovy Vary

205.365.1077 Boehringer Ingelheim Investigational Site, Liberec

205.365.1079 Boehringer Ingelheim Investigational Site, Neratovice

205.365.1116 Boehringer Ingelheim Investigational Site, Pardubice

205.365.1062 Boehringer Ingelheim Investigational Site, Prague

205.365.1083 Boehringer Ingelheim Investigational Site, Prague

205.365.1117 Boehringer Ingelheim Investigational Site, Prague

205.365.1075 Boehringer Ingelheim Investigational Site, Strakonice

205.365.1063 Boehringer Ingelheim Investigational Site, Tábor

205.365.1076 Boehringer Ingelheim Investigational Site, Ústí nad Labem

205.365.1055 Boehringer Ingelheim Investigational Site, Berlin

205.365.1066 Boehringer Ingelheim Investigational Site, Berlin

205.365.1054 Boehringer Ingelheim Investigational Site, Gelnhausen

205.365.1052 Boehringer Ingelheim Investigational Site, Rüdersdorf

205.365.1050 Boehringer Ingelheim Investigational Site, Ulm

205.365.1067 Boehringer Ingelheim Investigational Site, Athens

205.365.1127 Boehringer Ingelheim Investigational Site, Athens

205.365.1126 Boehringer Ingelheim Investigational Site, Thessaloniki

205.365.1070 Boehringer Ingelheim Investigational Site, Enschede

205.365.1072 Boehringer Ingelheim Investigational Site, Etten-Leur

205.365.1071 Boehringer Ingelheim Investigational Site, Spijkenisse

205.365.1069 Boehringer Ingelheim Investigational Site, Zutphen

205.365.1025 Boehringer Ingelheim Investigational Site, Amadora

205.365.1020 Boehringer Ingelheim Investigational Site, Coimbra

205.365.1022 Boehringer Ingelheim Investigational Site, Lisbon

205.365.1128 Boehringer Ingelheim Investigational Site, Dnipropetrovsk

205.365.1108 Boehringer Ingelheim Investigational Site, Kharkiv

205.365.1110 Boehringer Ingelheim Investigational Site, Kharkiv

205.365.1112 Boehringer Ingelheim Investigational Site, Kharkiv

205.365.1114 Boehringer Ingelheim Investigational Site, Kiev

205.365.1115 Boehringer Ingelheim Investigational Site, Kiev

205.365.1113 Boehringer Ingelheim Investigational Site, Simferopol

205.365.44002 Boehringer Ingelheim Investigational Site, Garston, Watford

205.365.44003 Boehringer Ingelheim Investigational Site, Harrow

205.365.44004 Boehringer Ingelheim Investigational Site, Warminster